Insilico Medicine initiates AI driven collaboration with leading global cancer center to identify novel targets for gastroesophageal cancers
Business Announcement
Updates every hour. Last Updated: 23-Jun-2026 05:16 ET (23-Jun-2026 09:16 GMT/UTC)
Cambridge, MA, February 17, 2025 — Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and Memorial Sloan Kettering Cancer Center (MSK) have entered into a collaborative research agreement aimed at discovering new therapeutic targets for gastroesophageal malignancies. The initiative builds on MSK’s global leadership in this field under the direction of Yelena Y. Janjigian, MD, Carroll and Milton Petrie Chair; Chief, GI Oncology; and Founding Director of the MSK GEC Therapeutics Accelerator, whose group has delivered multiple practice-changing advances in gastric and gastroesophageal junction cancers. Patrick Evans, BS, MBA, Senior Project Manager in the Janjigian Lab, will serve as the MSK project lead, supporting integration of scientific, operational, and translational efforts across teams.
MIT chemical engineers used AI to optimize the selection of codon sequences for protein drugs produced by yeast, which could reduce the costs of developing and manufacturing these drugs.
Subsidies enacted a year into the COVID-19 pandemic to expand eligibility and offset premium costs of insurance purchased on Affordable Care Act (ACA) marketplaces led to significant enrollment gains among eligible children ages 18 and under, Black and Hispanic individuals, and residents of rural areas, according to a new study by a researcher at the Johns Hopkins Bloomberg School of Public Health.
)— As the population ages, renewed attention is being given to the institutional buildings where many older adults reside, such as nursing homes and long-term care settings, which affect the health and quality of life of those living in them. Research suggests that built spaces exert strong and subtle influences on the brains and bodies of aging persons. For example, the way space is designed can play a role in the risk of falling, infection control, avoidable hospitalization and confusion.
Unfortunately, this research is not currently incorporated in a systematic way into new construction or renovation projects. A multidisciplinary team led by Boston University Chobanian & Avedisian School of Medicine has developed a framework for evaluating long-term care architectural drawings and designs. Entitled “Bioethics Peer Review for Long-Term Care Design (BPR-LTC),” the framework’s intent is for evidence-based design principles to be incorporated into the development of spaces for older adults.